Search for: "State v. Tri-State Pharmaceutical" Results 221 - 240 of 455
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Jan 2014, 7:21 am by John Elwood
Merrell Dow Pharmaceuticals, Inc. [read post]
23 Dec 2013, 5:16 am
  As last year’s Bartlett decision demonstrated, the First Circuit has recently been an extreme outlier on a variety of matters having to do with pharmaceutical liability. [read post]
21 Nov 2013, 12:13 pm
  The FDA’s brief cited Sigma-Tau Pharmaceuticals, Inc. v. [read post]
1 Nov 2013, 9:04 pm by Lyle Denniston
  It relied very heavily upon the 1920 precedent in Missouri v. [read post]
5 Sep 2013, 12:24 pm by Bexis
  It appears from the opinion, id., that the defendant tried to extend Mensing/Mutual Pharmaceutical Co. v. [read post]
19 Aug 2013, 10:20 am by Bexis
Aug. 15, 2013), put it squarely in the red in explaining why no type of design defect claims survive preemption in generic drug cases after Mutual Pharmaceutical Co. v. [read post]
30 Jul 2013, 2:53 pm
One such case is Generics [UK] Ltd (t/a Mylan) v Yeda Research And Development Co Ltd and Teva Pharmaceutical Industries Ltd [2013] EWCA Civ 925, decided yesterday by a three-man Court of Appeal for England and Wales which consisted of two specialist IP judges -- Lords Justices Kitchin and Floyd -- together with Lord Justice Moses. [read post]
8 Jul 2013, 8:10 am by Michelle Yeary
  The decision on appeal is the Fifth Circuit’s Mississippi v. [read post]